Scientific Article
previous document  unige:100727  next document
add to browser collection

Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2

Birkenfeld, Andreas L
Jurczak, Michael J
Kanda, Shoichi
Guigni, Blas A
Jiang, Debbie C
Zhang, Dongyan
Lee, Hui-Young
show hidden authors show all authors [1 - 10]
Published in Proceedings of the National Academy of Sciences of the United States of America. 2011, vol. 108, no. 14, p. 5748-52
Abstract Mice overexpressing acylCoA:diacylglycerol (DAG) acyltransferase 2 in the liver (Liv-DGAT2) have been shown to have normal hepatic insulin responsiveness despite severe hepatic steatosis and increased hepatic triglyceride, diacylglycerol, and ceramide content, demonstrating a dissociation between hepatic steatosis and hepatic insulin resistance. This led us to reevaluate the role of DAG in causing hepatic insulin resistance in this mouse model of severe hepatic steatosis. Using hyperinsulinemic-euglycemic clamps, we studied insulin action in Liv-DGAT2 mice and their wild-type (WT) littermate controls. Here, we show that Liv-DGAT2 mice manifest severe hepatic insulin resistance as reflected by decreased suppression of endogenous glucose production (0.8 ± 41.8 vs. 87.7 ± 34.3% in WT mice, P < 0.01) during the clamps. Hepatic insulin resistance could be attributed to an almost 12-fold increase in hepatic DAG content (P < 0.01) resulting in a 3.6-fold increase in protein kinase Cε (PKCε) activation (P < 0.01) and a subsequent 52% decrease in insulin-stimulated insulin receptor substrate 2 (IRS-2) tyrosine phosphorylation (P < 0.05), as well as a 64% decrease in fold increase pAkt/Akt ratio from basal conditions (P < 0.01). In contrast, hepatic insulin resistance in these mice was not associated with increased endoplasmic reticulum (ER) stress or inflammation. Importantly, hepatic insulin resistance in Liv-DGAT2 mice was independent of differences in body composition, energy expenditure, or food intake. In conclusion, these findings strengthen the link between hepatic steatosis and hepatic insulin resistance and support the hypothesis that DAG-induced PKCε activation plays a major role in nonalcoholic fatty liver disease (NAFLD)-associated hepatic insulin resistance.
Keywords Analysis of VarianceAnimalsBlood GlucoseCytokines/bloodDiacylglycerol O-Acyltransferase/metabolismEndoplasmic Reticulum/metabolismFatty Acids/bloodFatty Liver/metabolismImmunoprecipitationInsulin Receptor Substrate Proteins/metabolismInsulin Resistance/physiologyLiver/enzymologyMiceMicropore FiltersPhosphorylationProtein Kinase C-epsilon/metabolismReverse Transcriptase Polymerase Chain Reaction
PMID: 21436037
Full text
Article (Published version) (1.1 MB) - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
JORNAYVAZ, François et al. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. In: Proceedings of the National Academy of Sciences, 2011, vol. 108, n° 14, p. 5748-52. doi: 10.1073/pnas.1103451108

223 hits

0 download


Deposited on : 2017-12-21

Export document
Format :
Citation style :